Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer c1
The European Association for the Study of the Liver (EASL) has published an update of its guidelines for the management of hepatocellular carcinoma (1
A team of researchers from the Clínic-IDIBAPS have analysed the capacity of an artificial intelligence model to classify liver lesions after a magnet1
Hepatocellular carcinoma is the most common primary liver tumor and is currently one of the leading causes of cancer-related mortality. In most cases1
Researchers from Hospital Clínic-IDIBAPS and the CIBER for Liver and Digestive Diseases (CIBEREHD) have identified factors that can help predict whic1
IDIBAPS looks for talented professionals to meet the needs that appear periodically.
Enter